ANGN BIOM |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.1 USD | +1.22% |
|
+7.02% | -9.00% |
| 2023 | Angion Biomedica Corp. Announces Resignation of Assaf Segal from Its Board of Directors | CI |
| 2023 | Angion Biomedia to Implement 10-for-1 Reverse Split | MT |
Valuation
| Fiscal Period: December | 2021 | 2022 |
|---|---|---|
| Capitalization 1 | 86.87 | 24.44 |
| Enterprise Value (EV) 1 | 2.78 | -22.34 |
| P/E ratio | -1.5 x | -0.63 x |
| Yield | - | - |
| Capitalization / Revenue | 3.07 x | 10.6 x |
| EV / Revenue | 0.1 x | -9.71 x |
| EV / EBITDA | -0.07 x | 0.74 x |
| EV / FCF | -122,333 x | 1,082,494 x |
| FCF Yield | -0% | 0% |
| Price to Book | 1.07 x | 0.56 x |
| Nbr of stocks (in thousands) | 2,996 | 3,011 |
| Reference price 2 | 29.00 | 8.116 |
| Announcement Date | 3/30/22 | 3/17/23 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Net sales 1 | 4.029 | 1.487 | 2.88 | 28.31 | 2.301 |
| EBITDA 1 | -14.34 | -38.54 | -55.12 | -39.22 | -30.26 |
| EBIT 1 | -14.34 | -38.59 | -55.22 | -39.31 | -30.44 |
| Operating Margin | -355.97% | -2,595.23% | -1,917.19% | -138.84% | -1,322.73% |
| Earnings before Tax (EBT) 1 | -20.02 | -40.66 | -80.11 | -54.57 | -38.81 |
| Net income 1 | -20.02 | -40.66 | -80.11 | -54.57 | -38.81 |
| Net margin | -497.02% | -2,734.23% | -2,781.49% | -192.76% | -1,686.53% |
| EPS 2 | -25.77 | -28.17 | -54.27 | -19.32 | -12.92 |
| Free Cash Flow | - | -8.558 | -27.03 | -22.72 | -20.63 |
| FCF margin | - | -575.55% | -938.68% | -80.26% | -896.76% |
| FCF Conversion (EBITDA) | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 1/15/21 | 1/15/21 | 3/30/21 | 3/30/22 | 3/17/23 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Net Debt 1 | - | 5.21 | 50.4 | - | - |
| Net Cash position 1 | 25.5 | - | - | 84.1 | 46.8 |
| Leverage (Debt/EBITDA) | - | -0.1351 x | -0.9151 x | - | - |
| Free Cash Flow | - | -8.56 | -27 | -22.7 | -20.6 |
| ROE (net income / shareholders' equity) | - | -25,020% | 147% | 1,221% | -62% |
| ROA (Net income/ Total Assets) | - | -125% | -117% | -34.2% | -25.5% |
| Assets 1 | - | 32.46 | 68.75 | 159.8 | 152.3 |
| Book Value Per Share 2 | 19.50 | -12.90 | -59.10 | 27.20 | 14.50 |
| Cash Flow per Share 2 | 26.30 | 3.860 | 22.60 | 29.60 | 16.80 |
| Capex | - | 0.24 | 0.04 | 0.38 | - |
| Capex / Sales | - | 16.27% | 1.42% | 1.35% | - |
| Announcement Date | 1/15/21 | 1/15/21 | 3/30/21 | 3/30/22 | 3/17/23 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- ANGN Stock
- Financials ANGN BIOM
